Clinical Trial Update: Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 safety study evaluating chemotherapy combined with a dendritic cell vaccine in breast cancer patients; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Dendritic cell vaccine

Snippet

Sponsor: Baylor Research Institute | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-13